Common CH‐associated mutations include DNMT3A, TET2 and ASXL1 (‘DTA’ mutations) and, despite being found in AML, are not helpful for MRD monitoring as these DTA mutations are not lost even in remission [28]. Here, TET2 is linked to acute myeloid leukemia.